Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene
Authors:
Open Access
- 25 June 2024
- journal article
- research article
- Published by Elsevier in Stem Cell Research
- Vol. 79, 103485
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association (869015)
- American Heart Association (23POST1020812)
- National Institutes of Health
- NHLBI (R01 HL158641)
- NHLBI (R01 HL161002)
This publication has 5 references indexed in Scilit:
- Generation of induced pluripotent stem cell line from a patient suffering from arterial calcification due to deficiency of CD73 (ACDC)Stem Cell Research, 2023
- Endovascular Management of Vascular Complications in Ehlers–Danlos Syndrome Type IVJournal of Clinical Medicine, 2022
- Clinical trial in a dish using iPSCs shows lovastatin improves endothelial dysfunction and cellular cross-talk in LMNA cardiomyopathyScience Translational Medicine, 2020
- Vascular Ehlers-Danlos SyndromeJACC, 2019
- The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers–Danlos syndromeEuropean Journal of Human Genetics, 2015